Back to Browse Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 1

Factors affecting therapeutic compliance: A review from the patient’s perspective

Authors Jing Jin, Grant Edward Sklar, Vernon Min Sen Oh, Shu Chuen Li

Published Date March 2008 Volume 2008:4(1) Pages 269—286

DOI http://dx.doi.org/10.2147/TCRM.S1458

Published 5 March 2008

Jing Jin1, Grant Edward Sklar1, Vernon Min Sen Oh2, Shu Chuen Li3

1Department of Pharmacy, National University of Singapore, Republic of Singapore; 2Department of Clinical Pharmacology and Therapeutics, Yong Loo Lin School of Medicine, National University of Singapore, Republic of Singapore; 3Discipline of Pharmacy and Experimental Pharmacology, School of Biomedical Sciences, University of Newcastle, Callaghan, Australia

Objective: To explore and evaluate the most common factors causing therapeutic noncompliance.

Methods: A qualitative review was undertaken by a literature search of the Medline database from 1970 to 2005 to identify studies evaluating the factors contributing to therapeutic non-compliance.

Results: A total of 102 articles was retrieved and used in the review from the 2095 articles identified by the literature review process. From the literature review, it would appear that the definition of therapeutic compliance is adequately resolved. The preliminary evaluation revealed a number of factors that contributed to therapeutic non-compliance. These factors could be categorized to patient-centered factors, therapy-related factors, social and economic factors, healthcare system factors, and disease factors. For some of these factors, the impact on compliance was not unequivocal, but for other factors, the impact was inconsistent and contradictory.

Conclusion: There are numerous studies on therapeutic noncompliance over the years. The factors related to compliance may be better categorized as “soft” and “hard” factors as the approach in countering their effects may differ. The review also highlights that the interaction of the various factors has not been studied systematically. Future studies need to address this interaction issue, as this may be crucial to reducing the level of non-compliance in general, and to enhancing the possibility of achieving the desired healthcare outcomes.

Keywords: patient compliance, adherence, factors

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Depressive disorders co-existing with Addison–Biermer anemia – case report

Just MJ, Kozakiewicz M

Neuropsychiatric Disease and Treatment 2015, 11:1145-1148

Published Date: 30 April 2015

Delivery as nanoparticles reduces imatinib mesylate-induced cardiotoxicity and improves anticancer activity

Marslin G, Revina AM, Khandelwal VKM, Balakumar K, Prakash J, Franklin G, Sheeba CJ

International Journal of Nanomedicine 2015, 10:3163-3170

Published Date: 24 April 2015

Dietary patterns and schizophrenia: a comparison with healthy controls

Tsuruga K, Sugawara N, Sato Y, Saito M, Furukori H, Nakagami T, Nakamura K, Takahashi I, Nakaji S, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2015, 11:1115-1120

Published Date: 22 April 2015

Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis

Taveira-DaSilva AM, Moss J

Clinical Epidemiology 2015, 7:249-257

Published Date: 7 April 2015

Water-soluble l-cysteine-coated FePt nanoparticles as dual MRI/CT imaging contrast agent for glioma

Liang SY, Zhou Q, Wang M, Zhu YH, Wu QZ, Yang XL

International Journal of Nanomedicine 2015, 10:2325-2333

Published Date: 23 March 2015

Tiotropium HandiHaler® and Respimat® in COPD: a pooled safety analysis

Halpin DMG, Dahl R, Hallmann C, Mueller A, Tashkin D

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:239-259

Published Date: 5 February 2015

Nanocomplexation of thrombin with cationic amylose derivative for improved stability and hemostatic efficacy

Zhuang B, Li Z, Pang J, Li W, Huang P, Wang J, Zhou Y, Lin Q, Zhou Q, Ye X, Ye H, Liu Y, Zhang LM, Chen R

International Journal of Nanomedicine 2015, 10:939-947

Published Date: 29 January 2015

Children with hemodynamically significant congenital heart disease can be identified through population-based registers

Bergman G, Hærskjold A, Stensballe LG, Kieler H, Linder M

Clinical Epidemiology 2015, 7:119-127

Published Date: 23 January 2015

Cerebellar cryptococcosis characterized by a space-occupying lesion in an immunocompetent non-HIV patient

Liu BX, Dai XJ, Liu H, Gong HH, Wang YX, Zhang LL

Neuropsychiatric Disease and Treatment 2015, 11:21-24

Published Date: 19 December 2014

Diagnostic performance of a combination of Mini-Mental State Examination and Clock Drawing Test in detecting Alzheimer’s disease

Kato Y, Narumoto J, Matsuoka T, Okamura A, Koumi H, Kishikawa Y, Terashima S, Fukui K

Neuropsychiatric Disease and Treatment 2013, 9:581-586

Published Date: 30 April 2013